Get started
Author

Bariki Mtafya

Observed names: B Mtafya, B. Mtafya, Bariki A Mtafya, Mtafya Bariki, Mtafya, B., Mtafya, Bariki, Mtafya, Bariki A., Mtafya, Bariki Anyamkisye
ORCID: 0000-0003-3772-8671
Observed ORCID: 0000-0003-3772-8671
OpenAlex ID: A5063327384
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
2016 · Martin J Boeree, Norbert Heinrich, et al. · The Lancet Infectious Diseases · 378
PDF
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial
2016 · Jonny G Peter, Lynn S Zijenah, et al. · The Lancet · 273
Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study
2011 · Andrea Rachow, Alimuddin Zumla, et al. · PLoS ONE · 160
PDF
Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study
2012 · Andrea Rachow, Petra Clowes, et al. · Clinical Infectious Diseases · 148
PDF
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
2015 · Norbert Heinrich, Rodney Dawson, et al. · Journal of Antimicrobial Chemotherapy · 93
PDF
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay
2020 · Wilber Sabiiti, Khalide Azam, et al. · Thorax · 90
PDF
The Molecular Bacterial Load Assay Replaces Solid Culture for Measuring Early Bactericidal Response to Antituberculosis Treatment
2014 · Isobella Honeyborne, Bariki Mtafya, et al. · Journal of Clinical Microbiology · 75
PDF
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
2014 · Ruth Bowness, Martin J. Boeree, et al. · Journal of Antimicrobial Chemotherapy · 74
Noninfectious Comorbidity in the African Cohort Study
2018 · Julie A Ake, Christina S Polyak, et al. · Clinical Infectious Diseases · 67
PDF
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy
2018 · Mohamed I. M. Ahmed, Nyanda E. Ntinginya, et al. · Frontiers in Immunology · 56
PDF
Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania
2015 · Inge Kroidl, Petra Clowes, et al. · European Respiratory Journal · 55
PDF
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries
2023 · Laura Olbrich, Valsan P Verghese, et al. · The Lancet Infectious Diseases · 52
Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability
2019 · Bariki Mtafya, Wilber Sabiiti, et al. · Journal of Clinical Microbiology · 38
Why being an expert – despite xpert –remains crucial for children in high TB burden settings
2017 · Jason M. Bacha, Katherine Ngo, et al. · BMC Infectious Diseases · 33
PDF
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
2025 · Álvaro H Borges, Álvaro H Borges, et al. · The Lancet Infectious Diseases · 32
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
2025 · Norbert Heinrich, Veronique de Jager, et al. · The Lancet Microbe · 30
PDF
Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania [Short communication]
2012 · E. N. Ntinginya, S. B. Squire, et al. · The International Journal of Tuberculosis and Lung Disease · 29
Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study
2024 · Alexander Kay, Anca Vasiliu, et al. · The Lancet Microbe · 27
Tuberculosis Bacteria Detection and Counting in Fluorescence Microscopy Images Using a Multi-Stage Deep Learning Pipeline
2022 · Marios Zachariou, Ognjen Arandjelović, et al. · Information · 26
PDF
Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
2021 · Peter M. Mbelele, Emmanuel A. Mpolya, et al. · Journal of Clinical Microbiology · 25
Protein binding of rifampicin is not saturated when using high-dose rifampicin
2018 · Carlijn H C Litjens, Rob E Aarnoutse, et al. · Journal of Antimicrobial Chemotherapy · 21
PDF
Non-sputum-based samples and biomarkers for detection of Mycobacterium tuberculosis: the hope to improve childhood and HIV-associated tuberculosis diagnosis
2024 · George W. Kasule, Sabine Hermans, et al. · European journal of medical research · 20
PDF
Predictors and Barriers to Condom Use in the African Cohort Study
2020 · Tope Analogbei, Nicole Dear, et al. · AIDS Patient Care and STDs · 20
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
2020 · Wilber Sabiiti, Bariki Mtafya, et al. · Journal of Visualized Experiments · 18
PDF
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings
2016 · W. Sabiiti, B. Mtafya, et al. · The International Journal of Tuberculosis and Lung Disease · 16
PDF
Works count: 77
Citation count: 2,002
H-index: 21
I10-index: 30
Year
Topic
Type